ClinicalTrials.gov
ClinicalTrials.gov Menu

Community-Based Cognitive Therapy for Suicide Attempters

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00081367
Recruitment Status : Completed
First Posted : April 12, 2004
Last Update Posted : June 10, 2014
Sponsor:
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
Gregory Brown, University of Pennsylvania

Brief Summary:
This study will determine the effectiveness of cognitive behavioral therapy (CBT) in preventing future suicide attempts in repeat suicide attempters.

Condition or disease Intervention/treatment Phase
Suicide, Attempted Behavioral: CBT Behavioral: Standard care alone Phase 3

Detailed Description:

Rates of mental health and substance use disorders are high among economically disadvantaged, ethnic minority populations. Studies have shown that CBT designed for this high-risk population is successful at reducing suicide attempts in people with suicidal thoughts or attempts. This study will implement a CBT intervention into the community and will focus on increasing compliance with psychiatric, substance abuse, and medical treatment.

Participants in this study will be randomly assigned to receive either CBT plus standard care or standard care alone. Participants who receive CBT will have ten weekly sessions of treatment. Suicidal thoughts or attempts, hopelessness, depression, health care utilization, and overall psychological and social adaptation will be assessed. Assessments will be made 1, 3, 6, 12, 18, and 24 months after study completion.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 140 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Community-Based Cognitive Therapy for Suicide Attempters
Study Start Date : February 2004
Actual Primary Completion Date : November 2009
Actual Study Completion Date : November 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Suicide
U.S. FDA Resources

Arm Intervention/treatment
Experimental: Cognitive behavioral therapy (CBT) + standard care
Participants will receive ten weekly sessions of treatment plus standard care for suicide prevention.
Behavioral: CBT
Participants will receive ten weekly sessions of treatment. Suicidal thoughts or attempts, hopelessness, depression, health care utilization, and overall psychological and social adaptation will be assessed.
Behavioral: Standard care alone
Participants will receive standard care for suicide prevention.
Active Comparator: Standard care alone
Participants will receive standard care for suicide prevention.
Behavioral: Standard care alone
Participants will receive standard care for suicide prevention.



Primary Outcome Measures :
  1. Repeat suicide attempts [ Time Frame: Measured during treatment and 1, 3, 6, 12, 18, and 24 months after study completion ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Suicide attempt within 48 hours prior to being evaluated at the hospital
  • English speaking
  • Able to provide 2 verifiable contacts

Exclusion Criteria:

  • Acute, unstable, or severe Axis III disorder or a severe Axis I disorder that may prevent safe participation in outpatient psychotherapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00081367


Locations
United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
University of Pennsylvania
National Institute of Mental Health (NIMH)

Publications:
Responsible Party: Gregory Brown, Research Associate Professor of Clinical Psychology in Psychiatry, University of Pennsylvania
ClinicalTrials.gov Identifier: NCT00081367     History of Changes
Other Study ID Numbers: R01MH067805 ( U.S. NIH Grant/Contract )
R01MH067805 ( U.S. NIH Grant/Contract )
DSIR 83-ATP
First Posted: April 12, 2004    Key Record Dates
Last Update Posted: June 10, 2014
Last Verified: June 2014

Keywords provided by Gregory Brown, University of Pennsylvania:
Minority Groups

Additional relevant MeSH terms:
Suicide
Suicide, Attempted
Self-Injurious Behavior
Behavioral Symptoms